drugset / Trial / NCT01655992
A Trial Comparing S1 Generic With Capecitabine in Metastatic Breast Cancer (MBC)
RandomizedParallel-groupOpen-labelTreatment
Summary
Comparing S1 generic With Capecitabine in Patients With Metastatic Breast Cancer.
Timeline
- Start
- 2012-01
- Primary completion
- 2017-10
- Completion
- 2017-10
Outcome
Outcome not reported
Stopped: “The sponsor decided to stop the study.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Capecitabine | Small molecule | 2500 mg/m2 | — |
| Subject | S1 generic | Unknown | 40 mg/m2 | — |